MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
MANE — Veradermics, Incorporated
NYSEVeradermics, Incorporated
$108.96
-9.91(-8.34%)
- O
- 119.29
- H
- 119.29
- L
- 108.77
- V
- 734.91K
⏱️ End-of-day dataAs of Oct 6, 2026
Chart
About MANE
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateFeb 4, 2026
Employees21
Stock ExchangeNYSE
Ticker SymbolMANE
Websitehttps://www.veradermics.com
Key Financial Statistics
| Market Cap | $4.88B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $32.00 - $131.24 |
| 52-Week Avg Volume | 634.7K |
| VWAP | $112.20 |
| Transactions | 16,176 |
| Total Recorded Bars | 169 days |